Offshore Lubricants Market Expected To Trigger A Revenue Increase To USD 428.8 Million By 2022:Key Participant ExxonMobil Corp., Chevron, Royal Dutch Shell and Castrol

San Francisco, 26 December 2018,  Offshore Lubricants Market Analysis, By Application (Engine Oil, Hydraulic Oil, Gear Oil, Grease), By End-Use (Offshore Rigs, FPSOs, OSVs) and Segment Forecasts To 2022

The global offshore lubricants market is expected to reach USD 428.8 million by 2022, according to a new report by Grand View Research, Inc. Increasing deep sea exploration is expected to remain a key driving factor for global offshore lubricants market. Stringent regulations regarding threat to aquatic life on account of unregulated disposal of marine lubricants coupled with volatile petrochemicals pricing have led industry participants to develop bio-based alternatives. This trend is crucial in determining company’s product portfolio, thereby a vital determinant for market competition. 

Engine oil was the leading application segment with demand share exceeding 70% in 2014. Increasing maritime traffic coupled with rising requirement for offshore vessels is expected to drive this segment over the forecast period. Grease is expected to witness the highest growth of 3.3% from 2015 to 2022. 

Access Full Research Report On Offshore Lubricants Market  Analysis:

www.grandviewresearch.com/industry-analysis/offshore-lubricants-market

Further key findings from the report suggest:

·         Global offshore lubricants market demand was 98.8 kilo tons in 2014 and is expected to grow at a CAGR of 2.7% from 2015 to 2022.

·         Offshore support vessels (OSVs) were the leading end-users for offshore lubricants and accounted for 57.0% of total market volume in 2014. Increasing deepwater exploration, OSVs along with other offshore support systems is expected to drive lubricants demand in OSVs. FPSOs are expected to witness significant gain in its market size on account of their increasing adoption for deepwater exploration and production.

·         Asia Pacific was the largest consumer and accounted for over 27% of total market volume in 2014. The region is characterized by increasing offshore projects in Arabian Sea and South China Sea. Economic growth in Asia Pacific facilitated for greater maritime trade thereby increasing sea traffic.

·         Increasing offshore oil & gas production along Gulf of Mexico is expected to drive North America growth. The region is bound by U.S. EPA regulations regarding marine lubricants usage. EPA has established VGP (vessel general permit) guidelines for lubricants used in vessels operating within the U.S. maritime boundary.

·         Top four companies including ExxonMobil Corp., Chevron, Royal Dutch Shell and Castrol, accounted for over 45% of global offshore lubricants market in 2014. The industry is characterized by high degree of competition by integrated multinational companies. Major oil & gas companies have presence across the value chain, thereby intensifying competition. 

Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/petrochemicals-and-downstream-derivatives

Grand View Research has segmented the global offshore lubricants market on the basis of application, end-use and region:

Offshore Lubricants Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2022)

·         Engine Oil

·         Hydraulic Oil

·         Gear Oil

·         Grease

·         Others

Offshore Lubricants End-Use Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2022)

·         Offshore Rigs

·         FPSOs (Floating, Production, Storage & Offloading Vessels)

·         OSVs (Offshore Support Vessels)

Offshore Lubricants Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2022)

·         North America

·         Europe

·         Asia Pacific

·         Middle East

·         RoW

Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-offshore-lubricants-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com/

Messaging Security Market Expected To Trigger A Revenue Increase To USD 11.10 Billion By 2025:Key Participant Cisco Systems, Inc., Symantec Corp.

San Francisco, 24 December 2018,  Messaging Security Market Analysis By Product (Messaging Gateways, Email Protection, Anti-virus), By Deployment (Cloud, On-premise), By End-use, By Region, And Segment Forecasts, 2018 – 2025

The global messaging security market is expected to reach USD 11.10 billion by 2025, according to a new study by Grand View Research, Inc. The market is expected to witness a CAGR of 13.7% over the forecast period, owing to increasing demand for cloud-based secure messaging products and solutions is driving the growth of the market. This can be attributed to the increasing popularity of Software-as-a-Service (SaaS) and virtual appliance based solutions

Organizations are increasingly utilizing instant messaging applications for external and internal communication, as they are a faster and cheaper mode of communication. However, with the accelerating adoption of this mode of communication, it becomes increasingly important to secure the messaging infrastructure as the communication environment is no longer secure. Hence, it is highly vulnerable to external threats.

Moreover, the increasing adoption of mobile devices is acting as another key driving factor contributing to the market growth. The accelerating demand for mobile devices for smoother communication amongst enterprises and its employees, through a network protected against threats, is paving the way for the adoption of secure messaging solutions and thus, facilitating secure access to critical enterprise information.

Access Full Research Report On Messaging Security Market  Analysis:

www.grandviewresearch.com/industry-analysis/messaging-security-market

Further key findings from the study suggest:

·         The email protection segment dominated the product segment in 2016. Emails act as an important source of storing critical information. However, their high vulnerability to virus and spam attacks necessitates the application of security solutions to safeguard emails against threats

·         Cloud deployment is anticipated to become the preferred option of deployment for messaging security products and solutions, as it offers greater flexibility, convenience, accessibility, and easy maintenance

·         The corporate segment is expected to find the highest application in the next eight years. Corporates possess large amounts of critical data that is required to be safeguarded against external and internal threats

·         North America accounted for the largest share in 2016 owing to presence of prominent market players in this region, who are continuously working on developing new innovative technologies

·         The Asia Pacific regional market is expected to experience the highest growth over the next eight years. This can be attributed to the presence of emerging economies such as India, China, and Australia that are expected to augment their expenditure on security infrastructure

·         The list of key industry participants includes Cisco Systems, Inc., Symantec Corp., Trend Micro Inc., McAfee LLC, Barracuda Networks, Inc., Proofpoint, Inc., Panda Security, Clearswift, Forcepoint LLC, and Sophos Ltd.

Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/network-security-software-and-services

Grand View Research has segmented the global messaging security market on the basis of product, deployment, end-use, and region:

Product Scope (Revenue, USD Million; 2014 - 2025)

·         Anti-virus

·         Email Protection

·         Messaging Gateway

Deployment Scope (Revenue, USD Million; 2014 - 2025)

·         Cloud

·         On-premise

End-use Outlook (Revenue, USD Million; 2014 - 2025)

·         Corporate

·         Residence

Regional Outlook (Revenue, USD Million; 2014 - 2025)

·         North America

o    U.S.

o    Canada

·         Europe

o    UK

o    Germany

·         Asia Pacific

o    China

o    Japan

o    India

·         Latin America

o    Brazil

·         Middle East & Africa (MEA)

Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-messaging-security-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com/

PCOS Treatment Market Expected To Trigger A Revenue Increase To USD 5.1 Billion By 2025:Key Participant AstraZeneca, Bayer AG

San Francisco, 24 December 2018,  Polycystic Ovarian Syndrome (PCOS) Treatment Market Analysis By Drugs (Oral Contraceptives, Antiandrogen, Insulin-Sensitizing Agents, Antidepressants, Anti-obesity), By Surgery, And Segment Forecasts, 2018 - 2025

The global polycystic ovarian syndrome treatment market is expected to reach USD 5.1 billion by 2025, according to a new report by Grand View Research, Inc. According to the Centers of Disease Control & Prevention (CDC), Polycystic Ovary Syndrome (PCOS) is the most common cause of female infertility. Approximately 6% to 12% women of reproductive age suffer from PCOS in the U. S. Moreover, progression of this condition can lead to metabolic abnormalities, which may result in development of type 2 diabetes, if the syndrome is not treated on time. The severity of the disorder increases the risk of developing uterine and endometrial cancers in patients. Thus, early diagnosis and effective treatment are significant for successful recovery. 

Presently, no specific drug is commercially available for this condition. Thus, treating symptoms is the prime aim of the treatment regimen. Owing to the various symptoms associated with this syndrome, a range of drug class/combinations is used in the treatment. Therefore, market leaders are focusing on developing a specific drug/treatment to cure the root cause of this disease. AstraZeneca is one of the leaders involved in developing such a drug.

Access Full Research Report On Polycystic Ovarian Syndrome (PCOS) Treatment Market  Analysis:

www.grandviewresearch.com/industry-analysis/polycystic-ovarian-syndrome-pcos-treatment-market

Further Key Findings from the Study Suggest:

·         Constantly rising prevalence of PCOS is primarily driving the growth of this market across the globe

·         Initiatives undertaken by government bodies and market players to create awareness about benefits of early diagnosis and commercially available treatment for PCOS among women is boosting the market

·         Treatment of PCOS mainly includes lifestyle modification through balanced diet, exercise, and drugs such as oral contraceptives, antiandrogens, insulin-sensitizing agents, anti-obesity agents, and antidepressants

·         Surgical procedures such as ovarian wedge resection and laparoscopic ovarian drilling are preferred when patients do not respond to drug therapy

·         Insulin-sensitizing agents segment is dominating the market since these drugs are widely used for treatment of insulin resistance to prevent diabetes, which is a risk associated with PCOS

·         Oral Contraceptive Pills (OCPs) segment is expected to grow at the fastest rate followed by antiandrogen agents that are used for treating symptomatic conditions such as hirsutism and acne

·         North America is dominating the market followed by Europe. High awareness and availability of advanced healthcare facilities are factors responsible for the dominant share held by this region

·         Asia Pacific is expected to be the fastest growing region over the forecast period.Increasing government initiatives for raising awareness about symptoms & diagnosis of PCOS and available treatment are increasing the number of women being diagnosed with this syndrome in the region

·         China is one of the most lucrative markets with tremendous growth opportunities for global as well as local players owing to presence of a large pool of obese female population, which is at high risk of PCOS

·         Key players in the market include AstraZeneca, Bayer AG, Merck KGaA, Abbott, Sanofi, Pfizer, Inc., Bristol-Myer Squibb Company, and Novartis AG. The market also includes other emerging players such as Teva Pharmaceutical Industries Limited and Ferring Pharmaceuticals, Inc., which are expected to grow significantly in the near future.

Browse More Reports Of This Category By Grand View Research At:   www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the PCOS treatment market on the basis of drug class, surgery type, and region:

Drug Class Outlook (Revenue, USD Billion; 2014 - 2025)

·         Oral Contraceptives

·         Antiandrogens

·         Insulin Sensitizing Agent

·         Antidepressant

·         Anti-obesity

Surgery Outlook (Revenue, USD Billion; 2014 - 2025)

·         Ovarian Wedge Resection

·         Laparoscopic Ovarian Drilling

Regional Outlook (Revenue, USD Billion; 2014 - 2025)

·         North America

o    U.S.

o    Canada

·         Europe

o    Germany

o    UK

·         Asia Pacific

o    China

o    Japan

·         Latin America

o    Mexico

o    Brazil

·         MEA

o    South Africa

Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-polycystic-ovarian-syndrome-pcos-treatment-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com/